Abstract:Background: Vascular calcification is a prevalent complication in chronic kidney disease and contributes to increased cardiovascular morbidity and mortality. XBP1 (X-box binding protein 1), existing as the unspliced (XBP1u) and spliced (XBP1s) forms, is a key component of the endoplasmic reticulum stress involved in vascular diseases. However, whether XBP1u participates in the development of vascular calcification remains unclear. Methods: We aim to investigate the role of XBP1u in vascular calcification.XBP1u protein levels were reduced in high phosphate (Pi)-induced calcified vascular smooth muscle cells (VSMCs), calcified aortas from mice with adenine diet-induced chronic renal failure (CRF) and calcified radial arteries from CRF patients. Results: Inhibition of XBP1u rather than XBP1s upregulated in the expression of the osteogenic markers runt-related transcription factor 2 (Runx2) and msh homeobox2 (Msx2), and exacerbated high Pi-induced VSMC calcification, as verified by calcium deposition and Alizarin red S staining. In contrast, XBP1u overexpression in high Pi-induced VSMCs significantly inhibited osteogenic differentiation and calcification. Consistently, SMC-specific XBP1 deficiency in mice markedly aggravated the adenine diet- and 5/6 nephrectomy-induced vascular calcification compared with that in the control littermates. Further interactome analysis revealed that XBP1u bound directly to β-catenin, a key regulator of vascular calcification, via aa 205-230 in its C-terminal degradation domain. XBP1u interacted with β-catenin to promote its ubiquitin-proteasomal degradation and thus inhibited β-catenin/T-cell factor (TCF)-mediated Runx2 and Msx2 transcription. Knockdown of β-catenin abolished the effect of XBP1u deficiency on VSMC calcification, suggesting a β-catenin-mediated mechanism. Moreover, the degradation of β-catenin promoted by XBP1u was independent of glycogen synthase kinase 3β (GSK-3β)-involved destruction complex. Conclusions: Our study identified XBP1u as a novel endogenous inhibitor of vascular calcification by counteracting β-catenin and promoting its ubiquitin-proteasomal degradation, which represents a new regulatory pathway of β-catenin and a promising target for vascular calcification treatment.

Inhibition of RIPK1 alleviating vascular smooth muscle cells osteogenic transdifferentiation via Runx2

Inhibition of RIPK1/RIPK3 Ameliorates Osteoclastogenesis Through Regulating NLRP3-dependent NF-κB and MAPKs Signaling Pathways

SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease

C5a-C5aR1 induces endoplasmic reticulum stress to accelerate vascular calcification via PERK-eIF2α-ATF4-CREB3L1 pathway

Overexpression of miR-204-5p Alleviates Osteogenic Differentiation and Calcification of Human Aortic Vascular Smooth Muscle Cells by Targeting Calcium/Calmodulin-dependent Protein Kinase 1

Shh–Gli2–Runx2 inhibits vascular calcification

Endothelial RIPK1 protects artery bypass graft against arteriosclerosis by regulating SMC growth

ERK1/2 inhibition reduces vascular calcification by activating miR-126-3p-DKK1/LRP6 pathway

Endoplasmic Reticulum Stress-Mediated Apoptosis is Activated in Vascular Calcification.

Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation

Regulatory Mechanism of CaMKII Δ Mediated by RIPK3 on Myocardial Fibrosis and Reversal Effects of RIPK3 Inhibitor GSK'872.

[Research on Potential Role of Receptor-interacting Protein Kinase 1 in Phenotype Switching of Vascular Smooth Muscle Cells].

CTRP13 Attenuates Vascular Calcification by Regulating Runx2

Unspliced XBP1 Counteracts β-catenin to Inhibit Vascular Calcification

Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in CKD

Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression.

The Role and Mechanism of RIPK1 in Vascular Endothelial Dysfunction in Chronic Kidney Disease.

Poly(ADP-ribose) polymerase 1 accelerates vascular calcification by upregulating Runx2

Activation of Nuclear Factor-Kappa B Accelerates Vascular Calcification by Inhibiting Ankylosis Protein Homolog Expression

Inhibition of FOXO1/3 promotes vascular calcification.

[Bax Inhibitor 1 Inhibits Vascular Calcification in Mice by Activating Optic Atrophy 1 Expression].